| Application no. and date | 96924553.9 (espacenet) (Federated) (European Patent Register), 19960716 | | Patent/reg. no. and date | DK/EP 0839132, 20010307 | | Publication date | 19980506 | | Priority no. and date | US 1453 P, 19950717, US 1453 P, 19950717 | | EP pub. no. and date |
EP 0839132 19980506 | | Effective date | | | Applicant/owner | WARNER-LAMBERT COMPANY, 201 Tabor Road, Morris Plains New Jersey 07950 , US | | Applicant ref. no. | 103075 | | Inventor | LIN, Min, 1808 Pheasant Hollow Drive
Plainsboro, NJ 08536, US,
SCHWEISS, Dieter, 320 Blue Isle Drive
Holland, MI 49424, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | C07D 207/34 (2006.01) | | Title | Fremgangsmåde til fremstilling af amorft [R-(R*,R*)]-2-(4-fluorphenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-heptansyrecalciumsalt (2:1) | | Int. application no. | US1996011807 | | Int. publication no. | WO1997003960 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
